Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schnurr

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 10, 2015
Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicityChristian Bauer, Claudia Hees, Alexander Sterzik, et al.
Cancer Research|January 23, 2013
Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancerJonathan Ellermeier, Jiwu Wei, Peter Duewell, et al.
Blood|November 18, 2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen deliveryMax Schnurr, Qiyuan Chen, Amanda Shin, et al.
Journal for Immunotherapy of Cancer|December 18, 2019
Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancerPhilipp Metzger, Sabrina V Kirchleitner, Michael Kluge, et al.
Journal for Immunotherapy of Cancer|November 8, 2019
Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancerPhilipp Metzger, Sabrina V Kirchleitner, Michael Kluge, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2020
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer modelPhilipp Metzger, Sabrina V Kirchleitner, Daniel F R Boehmer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2013
Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cellsSebastian Kobold, Stefanie Völk, Till Clauditz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cellsPeter Duewell, Ulrich Kisser, Klaus Heckelsmiller, et al.
Frontiers in Immunology|October 22, 2019
IFN Regulatory Factor 4 Controls Post-ischemic Inflammation and Prevents Chronic Kidney DiseaseGeorg Lorenz, Foteini Moschovaki-Filippidou, Vivian Würf, et al.
Blood|May 10, 2003
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuliMichael Jefford, Max Schnurr, Tracey Toy, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 10, 2015
Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicityChristian Bauer, Claudia Hees, Alexander Sterzik, et al.
Cancer Research|January 23, 2013
Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancerJonathan Ellermeier, Jiwu Wei, Peter Duewell, et al.
Blood|November 18, 2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen deliveryMax Schnurr, Qiyuan Chen, Amanda Shin, et al.
Journal for Immunotherapy of Cancer|December 18, 2019
Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancerPhilipp Metzger, Sabrina V Kirchleitner, Michael Kluge, et al.
Journal for Immunotherapy of Cancer|November 8, 2019
Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancerPhilipp Metzger, Sabrina V Kirchleitner, Michael Kluge, et al.
Cancer Immunology, Immunotherapy : CII|May 26, 2020
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer modelPhilipp Metzger, Sabrina V Kirchleitner, Daniel F R Boehmer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2013
Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cellsSebastian Kobold, Stefanie Völk, Till Clauditz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2011
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cellsPeter Duewell, Ulrich Kisser, Klaus Heckelsmiller, et al.
Frontiers in Immunology|October 22, 2019
IFN Regulatory Factor 4 Controls Post-ischemic Inflammation and Prevents Chronic Kidney DiseaseGeorg Lorenz, Foteini Moschovaki-Filippidou, Vivian Würf, et al.
Blood|May 10, 2003
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuliMichael Jefford, Max Schnurr, Tracey Toy, et al.
Pageof 7